Financial Management:

National Institutes of Health Research Invention Licenses and Royalties

AIMD-00-44R: Published: Nov 22, 1999. Publicly Released: Nov 22, 1999.

Additional Materials:


Gloria L. Jarmon
(202) 512-3000


Office of Public Affairs
(202) 512-4800

Pursuant to a congressional request, GAO provided information on issues related to the National Institutes of Health's (NIH) licensing of inventions developed under intramural research projects, focusing on the: (1) extent of and reasons for the differences between the number of research inventions licensed under cooperative research and development agreements (CRADA) compared to inventions licensed under other intramural research projects; and (2) internal controls that ensure proper accountability for royalty income resulting from these licenses.

GAO noted that: (1) for a number of reasons, the number of licenses granted for the use of federal inventions is not an appropriate measure for comparing CRADA and non-CRADA research projects; (2) the licensing information provided by NIH's Office of Technology Transfer for the period January 1994 through June 1999 did not present comparable data for CRADA and non-CRADA projects; (3) the 8 CRADA licenses were related to the 538 CRADAs established during this period, while the 1,021 non-CRADA licenses were related to research projects begun years or even decades earlier; (4) while the information provided appears to show that NIH licensed more inventions developed under non-CRADAs than it did under CRADAs, licensing opportunities are different; (5) according to NIH officials, less federal funding is involved in CRADA research than in non-CRADA research; (6) GAO performed limited testing of the internal controls over royalty income and found some deficiencies that could impact the completeness and accuracy of royalty income; (7) for example, NIH did not always promptly reconcile receipts, nor did it have integrated systems to track the royalty receipts; (8) further, while NIH had system documentation for the Invention Tracking System as implemented in 1992, that documentation had not been updated to reflect changes; and (9) therefore, if the system fails, it would be more difficult to make necessary repairs, thus potentially affecting normal operations and increasing the risk of lost royalty income.

Nov 18, 2020

Nov 17, 2020

Nov 13, 2020

Nov 12, 2020

Nov 4, 2020

Oct 26, 2020

Oct 8, 2020

Oct 1, 2020

Sep 30, 2020

Looking for more? Browse all our products here